Related Party Transactions (Details Narrative) - USD ($)						1 Months Ended	12 Months Ended
	Dec. 31, 2020	Jul. 27, 2020	Mar. 30, 2020	Aug. 13, 2019	Mar. 18, 2019	Oct. 31, 2018	Dec. 31, 2020	Dec. 31, 2019	Aug. 17, 2017
Value of common stock shares issued							$ 37,000	$ 56,000
Chief Operating Officer [Member]
Related party payables	$ 71,000						71,000	71,000
Transactions fixed annual amount						$ 280,000
Alfred D. Kingsley [Member]
Warrants to purchase of common stock					248,600
Warrants exercise price					$ 2.50
Payment of warrants					$ 621,500
Lineage [Member]
Related party payables								$ 7,000
Shared Facilities and Service Agreement [Member]
Allocated cost percentage									5.00%
New Loan Agreement [Member]
Line of credit, maximum borrowing capacity			$ 8,000,000
Stock issued during period, shares		28,500	28,500
Additional loan amount			$ 1,000,000
Line of credit, term			18 months
Line of credit, expiration date			Mar. 30, 2023
Default amount	1,000,000						$ 1,000,000
New Loan Agreement [Member] | Juvenescence's Discretion [Member]
Line of credit, maximum borrowing capacity			$ 1,000,000
Line of credit borrowed money in excess			500,000
Borrowed an aggregate amount			$ 3,000,000
2019 Loan Agreement [Member] | Juvenescence [Member]
Line of credit borrowed money in excess				$ 100,000
Line of credit, term				18 months
Line of credit outstanding amount	$ 2,000,000
Related party transaction description				On August 13, 2019, AgeX and Juvenescence entered into a Loan Facility Agreement (the "2019 Loan Agreement") pursuant to which Juvenescence has provided to AgeX a $2.0 million line of credit for a period of 18 months. As of December 31, 2020, AgeX had drawn the full $2.0 million line of credit.
Line of credit facility				$ 2,000,000
Increase in line of credit				$ 4,000,000
Number of common stock shares issued				19,000
Value of common stock shares issued				$ 56,000
Related party transaction percent				10.00%
Gross proceeds from sale of common stock				$ 7,500,000
Line of credit borrowed money in excess not paid				$ 25,000
Warrants to purchase of common stock				150,000
Warrants exercise price				$ 2.60
Warrants, value				$ 236,000
Number of shares issuable				19,000
Issuance of warrants				150,000